Anesthesia & Respiratory Devices

Global Anesthesia & Respiratory Devices Market to Reach US$36.9 Billion by 2032

The global market for Anesthesia & Respiratory Devices estimated at US$26.6 Billion in the year 2025, is expected to reach US$36.9 Billion by 2032, growing at a CAGR of 4.8% over the analysis period 2025-2032. Respiratory Devices, one of the segments analyzed in the report, is expected to record a 5.1% CAGR and reach US$23.8 Billion by the end of the analysis period. Growth in the Anesthesia Devices segment is estimated at 4.2% CAGR over the analysis period.

The U.S. Market is Estimated at US$8.2 Billion While China is Forecast to Grow at 8.8% CAGR

The Anesthesia & Respiratory Devices market in the U.S. is estimated at US$8.2 Billion in the year 2025. China, the world`s second largest economy, is forecast to reach a projected market size of US$9.1 Billion by the year 2032 trailing a CAGR of 8.8% over the analysis period 2025-2032. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.3% and 4.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.2% CAGR.

Global Anesthesia & Respiratory Devices Market - Key Trends and Drivers Summarized

What Are Anesthesia & Respiratory Devices, And Why Are They So Essential?

Anesthesia and respiratory devices play a pivotal role in modern healthcare by ensuring patient safety during surgery, medical procedures, and in the management of chronic respiratory conditions. Anesthesia devices are designed to deliver a controlled amount of anesthetic gases to patients, allowing them to undergo surgeries and other invasive procedures without pain or awareness. These systems consist of complex components, including ventilators, monitors, vaporizers, and breathing circuits, all working together to administer precise doses of anesthesia while maintaining respiratory function. On the other hand, respiratory devices cover a wide range of equipment used to support or enhance breathing, particularly for patients suffering from respiratory conditions such as chronic obstructive pulmonary disease (COPD), asthma, or sleep apnea. These devices include ventilators, oxygen concentrators, inhalers, and nebulizers, all of which are vital in both acute and chronic care settings. As medical science continues to advance, these devices have become increasingly sophisticated, offering more precise control and monitoring capabilities that improve patient outcomes and reduce the risks associated with anesthesia and respiratory compromise.

How Do Anesthesia & Respiratory Devices Benefit Various Healthcare Applications?

Anesthesia and respiratory devices are indispensable across numerous healthcare settings, from operating rooms and intensive care units to outpatient clinics and even home care environments. In surgical settings, anesthesia devices allow for the precise administration of anesthetics, maintaining the patient’s unconsciousness and controlling their vital functions such as breathing and circulation. These devices are especially important in complex and prolonged surgeries where the patient’s body needs to be closely monitored to ensure stability throughout the procedure. Respiratory devices, meanwhile, are crucial for patients with breathing difficulties. Ventilators, for instance, are used to support patients who cannot breathe adequately on their own, whether due to an acute condition like pneumonia or as part of long-term treatment for chronic diseases such as COPD. Home-based respiratory devices, such as continuous positive airway pressure (CPAP) machines for sleep apnea, allow patients to manage their conditions outside of a hospital, improving quality of life and reducing the need for hospitalization. The use of portable oxygen concentrators has similarly revolutionized care for patients with chronic respiratory diseases, offering greater mobility and independence. As the global population ages and the prevalence of respiratory illnesses rises, the demand for these devices in various healthcare settings continues to expand, making them a cornerstone of patient care.

What Types of Anesthesia & Respiratory Devices Are Available, And How Do They Differ?

The variety of anesthesia and respiratory devices reflects the diverse needs they address in clinical and home care environments. Anesthesia devices encompass several key components, including anesthesia machines, ventilators, and monitoring systems. Modern anesthesia machines are highly advanced, integrating ventilators that automatically adjust to the patient’s breathing needs, while also incorporating monitoring equipment to track vital signs and ensure safe anesthesia delivery. These machines can deliver both inhalational anesthetics and intravenous drugs, with precise control over dosage and timing. Respiratory devices are similarly diverse, ranging from life-saving ventilators, which are critical in both intensive care units and during surgeries, to portable oxygen concentrators used by patients with chronic lung diseases. Inhalers and nebulizers are also commonly used to deliver medication directly into the lungs for conditions like asthma and COPD. CPAP machines, which help patients with sleep apnea by providing continuous airflow to keep airways open during sleep, are a vital part of home-based respiratory care. The differences in these devices largely reflect their intended uses—some are designed for long-term management of chronic conditions, while others are critical for acute care in hospital settings. In all cases, these devices are increasingly incorporating digital technology, allowing for more accurate dosing, real-time monitoring, and data-driven care decisions.

What’s Driving the Growth in the Anesthesia & Respiratory Devices Market?

The growth in the anesthesia and respiratory devices market is driven by several factors, including the increasing prevalence of respiratory diseases, the rising number of surgeries worldwide, and technological advancements that are making these devices more effective and accessible. One of the primary drivers is the global rise in chronic respiratory conditions such as asthma, COPD, and sleep apnea, which is closely tied to factors like aging populations, urban pollution, and lifestyle changes. As the number of people affected by these conditions increases, so does the demand for respiratory support devices, especially those designed for long-term use in home care settings. Additionally, the ongoing COVID-19 pandemic has highlighted the critical role of ventilators and other respiratory devices in managing severe respiratory infections, further boosting the market’s expansion. Another significant factor is the growing number of surgeries, driven by advances in medical science, which has increased the need for reliable anesthesia devices that ensure patient safety during complex procedures. Furthermore, the trend toward minimally invasive surgeries, which require precise anesthesia control, has contributed to the market’s growth. Technological advancements, such as the integration of digital monitoring, automation, and AI in both anesthesia and respiratory devices, are improving the accuracy of treatments, reducing the risk of complications, and enabling remote monitoring—making these devices more attractive to healthcare providers and patients alike. Lastly, there is a growing demand for portable and user-friendly devices that allow patients to manage chronic conditions at home, reducing hospital readmissions and healthcare costs, while improving patient autonomy and quality of life. This convergence of medical needs, technological innovation, and healthcare trends is fueling significant growth in the anesthesia and respiratory devices market.

SCOPE OF STUDY:

The report analyzes the Anesthesia & Respiratory Devices market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:
Product (Respiratory Devices, Anesthesia Devices)

Geographic Regions/Countries:
World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

SELECT PLAYERS -

• B. Braun Melsungen AG
• Charts Industries
• Drägerwerk AG & Co. KGaA
• Fisher & Paykel Healthcare Limited
• GE Healthcare
• Getinge AB
• Masimo Corporation
• Medtronic Plc
• Philips Healthcare
• ResMed

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher. Show more